VX-272
VX25-272-001
Phase 1 small_molecule active
Quick answer
VX-272 for Cystic Fibrosis is a Phase 1 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Cystic Fibrosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active